XML 85 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Share-based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Compensation  
Schedule of share-based compensation expense

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 31, 

 

    

2020

    

2019

 

 

(in thousands)

Cost of goods sold

 

$

86

 

$

144

Research and development

 

 

85

 

 

90

Selling and marketing

 

 

93

 

 

120

General and administrative

 

 

638

 

 

520

 

 

$

902

 

$

874

 

Schedule of weighted-average key assumptions used in determining fair value of options granted

 

 

 

 

 

 

 

 

Three Months Ended

 

 

    

March 31, 2020

 

Estimated dividend yield

 

 

 0

%

Expected stock price volatility

 

 

73.65

%

Weighted-average risk-free interest rate

 

 

1.00

%

Expected life of option in years

 

 

6.25

 

Weighted-average option fair value at grant

 

$

0.74

 

 

Summary of outstanding and exercisable options

 

 

 

 

 

 

 

 

 

 

 

 

    

 

Weighted-

 

 

 

 

 

Number of

 

Average

 

Intrinsic

 

    

Options

    

Exercise Price

    

Value

 

 

 

 

 

 

 

(in thousands)

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

4,430,966

 

$

5.551

 

$

53

Exercisable at December 31, 2019

 

1,518,972

 

$

8.735

 

$

31

Granted

 

1,897,250

 

 

1.141

 

 

 

Exercised

 

(833)

 

 

0.320

 

 

 

Expired, forfeited or cancelled

 

(221,513)

 

 

4.730

 

 

 

Outstanding at March 31, 2020

 

6,105,870

 

$

4.211

 

$

54

Exercisable at March 31, 2020

 

2,131,328

 

$

7.118

 

$

 4

 

Summary of outstanding RSUs

 

 

 

 

 

 

 

 

    

 

    

Weighted-

 

 

Number of

 

Average

 

 

RSUs

 

Fair Value

 

 

 

 

 

 

Outstanding at December 31, 2019

 

54,063

 

$

7.96

Granted

 

741,750

 

 

1.49

Vested

 

(11,563)

 

 

8.30

Expired, forfeited or cancelled

 

 —

 

 

 —

Outstanding at March 31, 2020

 

784,250

 

$

1.84